112 related articles for article (PubMed ID: 4066488)
1. Chemical modification of spiramycins. VI. Synthesis and antibacterial activities of 3,3''-di-O-acyl-4''-O-sulfonyl and 3,3''-di-O-acyl-4''-O-alkyl derivatives of spiramycin I.
Sano M; Sunazuka T; Tanaka H; Yamashita K; Okachi R; Omura S
J Antibiot (Tokyo); 1985 Oct; 38(10):1350-8. PubMed ID: 4066488
[TBL] [Abstract][Full Text] [Related]
2. Chemical modification of spiramycins. III. Synthesis and antibacterial activities of 4''-sulfonates and 4''-alkylethers of spiramycin I.
Sano H; Sunazuka T; Tanaka H; Yamashita K; Okachi R; Omura S
J Antibiot (Tokyo); 1984 Jul; 37(7):750-9. PubMed ID: 6469869
[TBL] [Abstract][Full Text] [Related]
3. Chemical modification of spiramycins. IV. Synthesis and in vitro and in vivo activities of 3'',4''-diacylates and 3,3'',4''-triacylates of spriamycin I.
Sano H; Sunazuka T; Tanaka H; Yamashita K; Okachi R; Omura S
J Antibiot (Tokyo); 1984 Jul; 37(7):760-72. PubMed ID: 6469870
[TBL] [Abstract][Full Text] [Related]
4. Structure activity relationships of spiramycins.
Omura S; Sano H; Sunazuka T
J Antimicrob Chemother; 1985 Jul; 16 Suppl A():1-11. PubMed ID: 3902764
[TBL] [Abstract][Full Text] [Related]
5. Chemical modification of spiramycins. I. Synthesis of the acetal derivatives of neospiramycin I.
Sano H; Inoue M; Yamashita K; Okachi R; Omura S
J Antibiot (Tokyo); 1983 Oct; 36(10):1336-44. PubMed ID: 6643282
[TBL] [Abstract][Full Text] [Related]
6. Chemical modification of spiramycins. V. Synthesis and antibacterial activity of 3'- or 4''-de-N-methylspiramycin I and their N-substituted derivatives.
Sano H; Tanaka H; Yamashita K; Okachi R; Omura S
J Antibiot (Tokyo); 1985 Feb; 38(2):186-96. PubMed ID: 3997666
[TBL] [Abstract][Full Text] [Related]
7. Chemical modification of spiramycins. II. Synthesis and antimicrobial activity of 4'-deoxy derivatives of neospiramycin I and their 12-(Z)-isomers.
Sano H; Inoue M; Omura S
J Antibiot (Tokyo); 1984 Jul; 37(7):738-49. PubMed ID: 6469868
[TBL] [Abstract][Full Text] [Related]
8. Acyl derivatives of 16-membered macrolides. I. Synthesis and biological properties of 3"-O-propionylleucomycin A5 (TMS-19-Q).
Sakakibara H; Okekawa O; Fujiwara T; Otani M; Omura S
J Antibiot (Tokyo); 1981 Aug; 34(8):1001-10. PubMed ID: 7319915
[TBL] [Abstract][Full Text] [Related]
9. Structure-activity relationships among the O-acyl derivatives of leucomycin. Correlation of minimal inhibitory concentrations with binding to Escherichia coli ribosomes.
Omura S; Nakagawa A; Sakakibara H; Okekawa O; Brandsch R
J Med Chem; 1977 May; 20(5):732-6. PubMed ID: 404425
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and antimicrobial evaluation of acyl derivatives of 16-membered macrolide antibiotics related to tylosin.
Kirst HA; Debono M; Toth JE; Truedell BA; Willard KE; Ott JL; Counter FT; Felty-Duckworth AM; Pekarek RS
J Antibiot (Tokyo); 1986 Aug; 39(8):1108-22. PubMed ID: 3759662
[TBL] [Abstract][Full Text] [Related]
11. Quantitative structure-activity relationships of O-acyl derivatives of leucomycin for antimicrobial and ribosome-binding activities.
Tanaka H; Moriguchi I; Hirono S; Omura S
Chem Pharm Bull (Tokyo); 1985 Jul; 33(7):2803-8. PubMed ID: 4085039
[No Abstract] [Full Text] [Related]
12. Acyl derivatives of 16-membered macrolides. II. Antibacterial activities and serum levels of 3"-O-acyl derivatives of leucomycin.
Sakakibara H; Okekawa O; Fujiwara T; Aizawa M; Omura S
J Antibiot (Tokyo); 1981 Aug; 34(8):1011-8. PubMed ID: 7319916
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and structure-activity studies of new 4''-O-acyltylosin derivatives of therapeutic interest.
Yoshioka T; Kiyoshima K; Maeda M; Sakamoto M; Ishikura T; Fukagawa Y; Sawa T; Hamada M; Naganawa H; Takeuchi T
J Antibiot (Tokyo); 1988 Nov; 41(11):1617-28. PubMed ID: 3198495
[TBL] [Abstract][Full Text] [Related]
14. Syntheses and antimicrobial activities of 9-O-acyl derivatives of tylosin and demycarosyltylosin.
Tsuzuki K; Matsubara H; Nakagawa A; Omura S
J Antibiot (Tokyo); 1986 Dec; 39(12):1784-7. PubMed ID: 3818453
[No Abstract] [Full Text] [Related]
15. Binding of [3H]tetrahydroleucomycin A3 to Escherichia coli ribosomes and the effect of 3"-O-acyl derivatives of leucomycins on the binding.
Omura S; Tanaka H; Inokoshi J; Sakakibara H; Fujiwara T
J Antibiot (Tokyo); 1982 Apr; 35(4):491-6. PubMed ID: 7047480
[TBL] [Abstract][Full Text] [Related]
16. Chemical modification of deltamycins. I. 4''-O-acyl analogs of deltamycins.
Shimauchi Y; Hori K; Sakamoto M; Mutoh Y; Fukagawa Y; Hori S; Ishikura T; Lein J
J Antibiot (Tokyo); 1980 Mar; 33(3):284-92. PubMed ID: 7380741
[TBL] [Abstract][Full Text] [Related]
17. Novel dimeric derivatives of leucomycins and tylosin, sixteen-membered macrolides.
Omura S; Miyano K; Matsubara H; Nakagawa A
J Med Chem; 1982 Mar; 25(3):271-5. PubMed ID: 7040661
[TBL] [Abstract][Full Text] [Related]
18. N-Substituted derivatives of 23-amino-4',23-dideoxymycaminosyl tylonolide. Synthesis and antibacterial activity.
Sakamoto S; Tsuchiya T; Tanaka A; Umezawa S; Hamada M; Umezawa H
J Antibiot (Tokyo); 1985 Apr; 38(4):477-84. PubMed ID: 4008340
[TBL] [Abstract][Full Text] [Related]
19. [Spiramycin derivatives. 1].
Takahira H
Jpn J Antibiot; 1970 Aug; 23(4):424-8. PubMed ID: 5312794
[No Abstract] [Full Text] [Related]
20. Biological properties of new acyl derivatives of tylosin.
Okamoto R; Tsuchiya M; Nomura H; Iguchi H; Kiyoshima K; Hori S; Inui T; Sawa T; Takeuchi T; Umezawa H
J Antibiot (Tokyo); 1980 Nov; 33(11):1309-15. PubMed ID: 7251472
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
